Pharmacology News and Research

Latest Pharmacology News and Research

Appropriate exercise programs can provide benefits to people with asthma

Appropriate exercise programs can provide valuable benefits to people with asthma, helping to reduce the severity of attacks or prevent them entirely, finds a new evidence review in The Cochrane Library.

25 Sep 2013

Cerebral imaging in patients with early symptoms of AD may have better clinical outcomes

Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results available to their doctors or themselves.

25 Sep 2013

Study shows need for improved detection of sepsis for all women in labor

Rates of severe sepsis and deaths from sepsis among U.S. women hospitalized for delivery have risen sharply over the last decade, reports a study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Sep 2013

Digital devices may contribute to pulse oximetry's role as 'fifth vital sign'

Do you have a smartphone in your pocket or purse? If so, you may be carrying the future of mobile medical monitoring technology, according to a special article in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

24 Sep 2013

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess ACE project grant, supporting cutting-edge research in cell biology.

From Cellectricon 21 Sep 2013

New research may help in regulation of tobacco products to protect public health

UC San Francisco will receive a five-year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health.

21 Sep 2013

New cellular switch could eventually inhibit growth of aggressive malignant brain tumor

Researchers at UT Southwestern Medical Center have identified a cellular switch that potentially can be turned off and on to slow down, and eventually inhibit the growth of the most commonly diagnosed and aggressive malignant brain tumor.

21 Sep 2013

An in-depth approach to examine placebo effect and its impact on doctor-patient relationship

The findings of a comprehensive review of the placebo phenomenon and its consequences for clinical medicine are contained in a new article, "Placebo and the New Physiology of the Doctor-Patient Relationship," (http://bit.ly/14QfSur) published in Physiological Reviews.

20 Sep 2013

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.

18 Sep 2013

GW researcher awarded NEI grant to study developmental origins of wakefulness in cerebral cortex

Matthew Colonnese, Ph.D., assistant professor of pharmacology and physiology at the George Washington University School of Medicine and Health Sciences, was awarded a $1,973,645 grant from the National Eye Institute to study developmental origins of wakefulness in the cerebral cortex, the region of the brain responsible for cognition and perception.

18 Sep 2013

Flecainide, encainide drugs increase risk of sudden cardiac death

Scientists have discovered that a drug which increases the risk of sudden cardiac death interacts with mistranslated protein-coding genes present in heart muscle.

17 Sep 2013

Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury

Rutaecarpine, an active component of the traditional Chinese medicine Tetradium ruticarpum, has been shown to improve myocardial ischemia reperfusion injury, mainly focusing on calcitonin gene-based targets.

17 Sep 2013

Relmada Therapeutics collaborates with the Malvern Consulting Group

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has signed a collaboration agreement with the Malvern Consulting Group as clinical and regulatory advisor.

16 Sep 2013

Genetic deficiency in autism linked to specific molecular and cellular consequences

Brown University researchers have traced a genetic deficiency implicated in autism in humans to specific molecular and cellular consequences that cause clear deficits in mice in how well neurons can grow the intricate branches that allow them to connect to brain circuits. The researchers also show in their study (online Sep. 12, 2013, in Neuron) that they could restore proper neuronal growth by compensating for the errant molecular mechanisms they identified.

13 Sep 2013

Using large doses of codeine may heighten sensitivity to pain

Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.

13 Sep 2013

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

To prepare a potential new prostate cancer drug, called Gamitrinib, for trial in humans, The Wistar Institute has received a $1.5 million grant from the US Department of Defense's Congressionally Directed Medical Research Program.

13 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

Protein plays important role in process of degradation of tumour cells, say researchers

When tumour cells no longer degrade themselves, cancer may develop. Using black skin cancer as an example, Bern Researchers have now shown that a protein plays an important role in the process of degradation of tumour cells. By reactivating this degradation therapeutically, you can virtually force tumours to digest themselves.

12 Sep 2013

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.

12 Sep 2013

Antioxidant substances in red wine, dark chocolate, olive oil linked with health benefits

The scientific spotlight focuses today on the healthful antioxidant substances in red wine, dark chocolate, olive oil, coffee, tea, and other foods and dietary supplements that are enticing millions of consumers with the promise of a healthier, longer life.

12 Sep 2013

Pharmacology News and Research

Latest Pharmacology News and Research

Appropriate exercise programs can provide benefits to people with asthma

Cerebral imaging in patients with early symptoms of AD may have better clinical outcomes

Study shows need for improved detection of sepsis for all women in labor

Digital devices may contribute to pulse oximetry's role as 'fifth vital sign'

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

New research may help in regulation of tobacco products to protect public health

New cellular switch could eventually inhibit growth of aggressive malignant brain tumor

An in-depth approach to examine placebo effect and its impact on doctor-patient relationship

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW researcher awarded NEI grant to study developmental origins of wakefulness in cerebral cortex

Flecainide, encainide drugs increase risk of sudden cardiac death

Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury

Relmada Therapeutics collaborates with the Malvern Consulting Group

Genetic deficiency in autism linked to specific molecular and cellular consequences

Using large doses of codeine may heighten sensitivity to pain

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

Omeros announces positive data from OMS824 Phase 1 clinical trial

Protein plays important role in process of degradation of tumour cells, say researchers

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

Antioxidant substances in red wine, dark chocolate, olive oil linked with health benefits

Industry Focus - Biopharma eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Pharmacology News and Research

Latest Pharmacology News and Research

Industry Focus - Biopharma eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in